HCC surveillance is essential in at-risk Chronic Hepatitis B patients, even if virologically suppressed or after HBsAg loss. Continue surveillance in all with cirrhosis, family history or HBsAg loss >50 years. Risk scores (PAGE-B, mPAGE-B, REACH-B, aMAP) can help personalise surveillance.
👍1
EBL vs APC for GAVE.pdf
4.1 MB
Endoscopic band ligation versus argon plasma coagulation in the treatment of gastric antral vascular ectasia: systematic review and meta-analysis.
GIE june 2025
❤1
AGA guidelines Crohn’s disease 2025.pdf
7 MB
AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease.
AGA 20 November 2025
❤1
PIIS0016508525061608 conv 0.png
1.9 MB
Spotlight: Pharmacologic Management of Moderate-to-Severe Crohn’s Disease
❤1
Whole Food Diet Induces Remission in Children and Young Adults With Mild to Moderate Crohn's Disease and Is More Tolerable Than Exclusive Enteral Nutrition: A Randomized Controlled Trial
👍1
PIIS0016508525059645.pdf
2.9 MB
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis.
For Summary press comment 👇
For Summary press comment 👇
AGA November 2025